[The cross-validation approach revealed CEGP1 and PRAME as major candidates for breast cancer biomarker development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE